Association between past medical history (PMH) of autoimmune events and adverse events of special interest (AESI).

2565Background: PD-1/ L1inhibitor therapy has become the standard of care for many advanced solid tumors. A notablelimitation of PD-1/ L1inhibitor therapy is the concern for AESI that are likely t...